Login| Sign Up| Help| Contact|

Patent Searching and Data


Title:
LRRC-15-BINDING PROTEIN CONSTRUCTS AND USES THEREOF
Document Type and Number:
WIPO Patent Application WO/2024/081729
Kind Code:
A3
Abstract:
Provided herein are antigen-binding protein constructs (ABPCs), antibodies, and antibody drug conjugates (ADCs) that bind LRRC15, and uses of the same.

Inventors:
GERA NIMISH (US)
FISKE BRIAN (US)
FITZGERALD KYLE MICHAEL (US)
Application Number:
PCT/US2023/076593
Publication Date:
May 16, 2024
Filing Date:
October 11, 2023
Export Citation:
Click for automatic bibliography generation   Help
Assignee:
MYTHIC THERAPEUTICS INC (US)
International Classes:
C07K16/28; A61K39/395; A61K47/68; A61P35/00; C07K16/30
Domestic Patent References:
WO2021202642A22021-10-07
WO2021022304A22021-02-04
WO2022157094A22022-07-28
WO2017095805A12017-06-08
WO2017095808A12017-06-08
WO2005094348A22005-10-13
WO2020247827A12020-12-10
WO2021050871A12021-03-18
WO2022216653A12022-10-13
Other References:
HINGORANI POOJA ET AL: "ABBV-085, Antibody-Drug Conjugate Targeting LRRC15, Is Effective in Osteosarcoma: A Report by the Pediatric Preclinical Testing Consortium", MOLECULAR CANCER THERAPEUTICS, vol. 20, no. 3, 1 March 2021 (2021-03-01), US, pages 535 - 540, XP055950975, ISSN: 1535-7163, Retrieved from the Internet DOI: 10.1158/1535-7163.MCT-20-0406
TRAIAN SULEA ET AL: "Structure-based engineering of pH-dependent antibody binding for selective targeting of solid-tumor microenvironment", MABS, vol. 12, no. 1, 28 November 2019 (2019-11-28), US, pages 1 - 15, XP055748452, ISSN: 1942-0862, DOI: 10.1080/19420862.2019.1682866
Attorney, Agent or Firm:
PADILLA, Garett M. et al. (US)
Download PDF: